Pay in 4 interest-free payments of $24.75 Learn more
Ships within 48 hours · Estimated delivery Sep 16 - Sep 21
IL-1b and IL-18
These results indicate that synthetic REV-ERB ligands that pharmacologically target the circadian rhythm may be beneficial in the treatment of sleep disorders as well as metabolic diseases
(2012) J Med Chem
BAY-876 showed good metabolic stability in vitro and high oral bioavailability in vivo
R-GNE-140 - CAS# 2003234-63-5 size:2mg solid IL-1b and IL-18R GNE 140, CAS No. 2003234 63 5, a novel potent lactate dehydrogenase (LDHA) inhibitor with IC50 3nM for LDHA and 5 nM for LDHB. In MIA PaCa 2 human pancreatic cells, LDHA inhibition rapidly affected global metabolism, although cell death only occurred after 2 d of continuous LDHA inhibition. Pancreatic cell lines that utilize oxidative phosphorylation (OXPHOS) rather than glycolysis were inherently resistant to GNE 140, but could be resensitized to
US$ 121.12
US$ 48.00
US$ 125.33
US$ 179.99